Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor
- PMID: 3311202
Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor
Abstract
The genetic sequences encoding the gibbon and human interleukin 3 (IL 3) proteins were molecularly cloned. The amino acid sequence of the mature gibbon IL 3 protein proved to share 93% homology with the corresponding human protein. We examined the effects of biosynthetic (recombinant) gibbon IL 3 on the proliferation and differentiation of an enriched population of human hematopoietic progenitors and compared the results with the effects of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). Gibbon IL 3 supported the formation of various types of single lineage as well as multilineage colonies by My-10+ bone marrow cells in the presence of human erythropoietin (Ep). In contrast, recombinant human GM-CSF supported the formation of single-lineage colonies and only a small number of multilineage colonies. Both IL 3 and GM-CSF had significant erythroid burst-promoting activity (BPA). Delayed addition of gibbon IL 3 to low serum culture of My-10+ marrow cells supported the formation of blast cell colonies with variable but high replating capability. Human GM-CSF was less effective than IL 3 in support of multipotential blast cell colonies. These results are analogous to the effects of murine IL 3 and GM-CSF on murine progenitors and support the notion that the primary factor for multipotential progenitors is IL 3.
Similar articles
-
Recombinant gibbon interleukin-3 acts synergistically with recombinant human G-CSF and GM-CSF in vitro.Blood. 1988 Jun;71(6):1596-600. Blood. 1988. PMID: 2453230
-
Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture.Blood. 1990 Jun 1;75(11):2118-29. Blood. 1990. PMID: 1693295
-
Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: comparison with human recombinant granulocyte and granulocyte-macrophage colony-stimulating factor.Proc Natl Acad Sci U S A. 1987 Oct;84(19):6765-9. doi: 10.1073/pnas.84.19.6765. Proc Natl Acad Sci U S A. 1987. PMID: 3498941 Free PMC article.
-
Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3.J Cell Physiol. 1987 Jun;131(3):458-64. doi: 10.1002/jcp.1041310319. J Cell Physiol. 1987. PMID: 3298286
Cited by
-
Why clinicians should be interested in interleukin-3.Blut. 1990 Dec;61(6):338-45. doi: 10.1007/BF01738546. Blut. 1990. PMID: 2291980 Review.
-
Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.J Exp Med. 1990 Aug 1;172(2):509-2. doi: 10.1084/jem.172.2.509. J Exp Med. 1990. PMID: 2373991 Free PMC article.
-
Influence of IL-3 functional fragment on cord blood stem cell ex vivo expansion and differentiation.Stem Cell Investig. 2016 Mar 4;3:6. doi: 10.3978/j.issn.2306-9759.2016.03.01. eCollection 2016. Stem Cell Investig. 2016. PMID: 27358898 Free PMC article.
-
Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.Proc Natl Acad Sci U S A. 1988 Jun;85(12):4360-4. doi: 10.1073/pnas.85.12.4360. Proc Natl Acad Sci U S A. 1988. PMID: 3288992 Free PMC article.
-
Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens.Jpn J Cancer Res. 1992 Jul;83(7):746-53. doi: 10.1111/j.1349-7006.1992.tb01975.x. Jpn J Cancer Res. 1992. PMID: 1381342 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials